deuterated bupropion (DeuteRx)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namedeuterated bupropion (DeuteRx)
Drug Alias Namedeuterated bupropion (Deuteria Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine receptors agonistsNorepinephrine reuptake inhibitorsNicotinic receptors antagonists
TargetsNorepinephrine transporterDopamine receptorsNicotinic receptors
Therapy Area/IndicationsDepressionTobacco Use Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDeuteria Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDeuteria Pharmaceuticals IncDeuterx
Active IndicationsN/A
Inactive IndicationsDepressionTobacco Use Disorder

Other Information

ATC CodeN/A
Related LinksN/A